UnitedHealth Group Incorporated (NYSE:UNH) is NorthCoast Asset Management LLC’s 5th Largest Position

NorthCoast Asset Management LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 184,839 shares of the healthcare conglomerate’s stock after purchasing an additional 1,267 shares during the quarter. UnitedHealth Group accounts for approximately 2.8% of NorthCoast Asset Management LLC’s portfolio, making the stock its 5th largest position. NorthCoast Asset Management LLC’s holdings in UnitedHealth Group were worth $68,936,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. First Manhattan Co. boosted its stake in UnitedHealth Group by 19.7% in the first quarter. First Manhattan Co. now owns 1,482,677 shares of the healthcare conglomerate’s stock worth $551,661,000 after buying an additional 243,529 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of UnitedHealth Group by 0.7% during the first quarter. The Manufacturers Life Insurance Company now owns 3,623,499 shares of the healthcare conglomerate’s stock valued at $1,348,195,000 after purchasing an additional 26,846 shares during the period. Veritas Asset Management LLP boosted its stake in shares of UnitedHealth Group by 0.4% during the first quarter. Veritas Asset Management LLP now owns 2,572,968 shares of the healthcare conglomerate’s stock valued at $957,324,000 after purchasing an additional 10,713 shares during the period. Cullen Frost Bankers Inc. boosted its stake in shares of UnitedHealth Group by 5.5% during the first quarter. Cullen Frost Bankers Inc. now owns 102,002 shares of the healthcare conglomerate’s stock valued at $37,952,000 after purchasing an additional 5,291 shares during the period. Finally, Reliant Investment Management LLC boosted its stake in shares of UnitedHealth Group by 2.0% during the first quarter. Reliant Investment Management LLC now owns 13,324 shares of the healthcare conglomerate’s stock valued at $4,957,000 after purchasing an additional 255 shares during the period. 86.16% of the stock is owned by institutional investors and hedge funds.

A number of analysts have recently weighed in on UNH shares. Truist upped their target price on UnitedHealth Group from $480.00 to $500.00 and gave the company a “buy” rating in a report on Friday, July 16th. Mizuho upped their target price on UnitedHealth Group from $394.00 to $455.00 and gave the company a “buy” rating in a report on Friday, May 7th. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 target price for the company in a report on Wednesday, April 21st. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $418.00 to $421.00 and gave the company a “buy” rating in a report on Tuesday, July 13th. Finally, Truist Securities increased their price objective on UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, July 16th. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $443.74.

Shares of NYSE UNH traded up $1.81 during trading on Thursday, hitting $416.45. The company had a trading volume of 31,006 shares, compared to its average volume of 3,381,326. The company has a 50 day simple moving average of $406.95. The company has a quick ratio of 0.74, a current ratio of 0.77 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a 12 month low of $289.64 and a 12 month high of $425.98. The company has a market capitalization of $393.00 billion, a price-to-earnings ratio of 27.41, a P/E/G ratio of 1.66 and a beta of 0.77.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.43 by $0.27. The company had revenue of $71.32 billion for the quarter, compared to the consensus estimate of $69.51 billion. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The firm’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter last year, the company earned $7.12 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 18.71 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 29th. Shareholders of record on Monday, June 21st were paid a $1.45 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend was Friday, June 18th. This represents a $5.80 dividend on an annualized basis and a yield of 1.39%. UnitedHealth Group’s payout ratio is presently 34.36%.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 60,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, July 16th. The stock was sold at an average price of $420.62, for a total value of $25,237,200.00. Following the sale, the director now owns 941,560 shares of the company’s stock, valued at approximately $396,038,967.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 8,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 20th. The stock was sold at an average price of $414.31, for a total value of $3,314,480.00. Following the completion of the sale, the director now directly owns 154,403 shares in the company, valued at approximately $63,970,706.93. The disclosure for this sale can be found here. In the last ninety days, insiders sold 79,301 shares of company stock worth $33,042,253. Corporate insiders own 0.80% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: How the Dogs of the Dow Strategy Works

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.